CompaniesBHV Pharma

BHV Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

191

By Phase

PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
Today
NCT02537470
Hover over trial bars to see details

Recent Trials

NCT02537470Lead Sponsor
Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes
PHASE2Completed
191 participants
Started: Jul 31, 2015 · Completed: Aug 31, 2016
Related Companies
Avolynt
acquired